{"title":"最大化1,3 β - d -葡聚糖检测对侵袭性真菌感染的诊断潜力","authors":"Sejal Morjaria , N. Esther Babady","doi":"10.1016/j.clinmicnews.2025.01.001","DOIUrl":null,"url":null,"abstract":"<div><div>Invasive fungal infections (IFIs) pose a serious threat to patients, particularly those who are immunocompromised. Timely and accurate diagnosis of IFIs is critical to improving outcomes, and conventional diagnostic methods often fall short. The 1,3 Beta-D-Glucan <strong>(</strong>BDG) assay has become a significant test in the early diagnosis and management of IFIs when used in the appropriate clinical context.</div></div>","PeriodicalId":39211,"journal":{"name":"Clinical Microbiology Newsletter","volume":"50 ","pages":"Pages 24-33"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Maximizing the diagnostic potential of 1,3 beta-D-glucan assays for invasive fungal infections\",\"authors\":\"Sejal Morjaria , N. Esther Babady\",\"doi\":\"10.1016/j.clinmicnews.2025.01.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Invasive fungal infections (IFIs) pose a serious threat to patients, particularly those who are immunocompromised. Timely and accurate diagnosis of IFIs is critical to improving outcomes, and conventional diagnostic methods often fall short. The 1,3 Beta-D-Glucan <strong>(</strong>BDG) assay has become a significant test in the early diagnosis and management of IFIs when used in the appropriate clinical context.</div></div>\",\"PeriodicalId\":39211,\"journal\":{\"name\":\"Clinical Microbiology Newsletter\",\"volume\":\"50 \",\"pages\":\"Pages 24-33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Microbiology Newsletter\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0196439925000017\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology Newsletter","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0196439925000017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
侵袭性真菌感染(IFIs)对患者构成严重威胁,特别是那些免疫功能低下的患者。国际金融机构的及时和准确诊断对于改善结果至关重要,而传统的诊断方法往往达不到要求。在适当的临床环境下,1,3 β - d -葡聚糖(BDG)测定已成为ifi早期诊断和管理的重要测试。
Maximizing the diagnostic potential of 1,3 beta-D-glucan assays for invasive fungal infections
Invasive fungal infections (IFIs) pose a serious threat to patients, particularly those who are immunocompromised. Timely and accurate diagnosis of IFIs is critical to improving outcomes, and conventional diagnostic methods often fall short. The 1,3 Beta-D-Glucan (BDG) assay has become a significant test in the early diagnosis and management of IFIs when used in the appropriate clinical context.
期刊介绍:
Highly respected for its ability to keep pace with advances in this fast moving field, Clinical Microbiology Newsletter has quickly become a “benchmark” for anyone in the lab. Twice a month the newsletter reports on changes that affect your work, ranging from articles on new diagnostic techniques, to surveys of how readers handle blood cultures, to editorials questioning common procedures and suggesting new ones.